Cancer Stem Cells Therapy Market Analysis & Forecast - 2032

Cancer Stem Cells Therapy Market Size - By Type (Targeted Cancer Stem Cells, Stem Cells-based), Cancer Type (Breast, Lung, Colorectal, Prostrate), End-user, Global Forecast (2023- 2032)

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast calculation

1.4&nbsp;&nbsp;&nbsp; Covid-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global cancer stem cells therapy market 3600&nbsp;synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Region trends

2.4&nbsp;&nbsp;&nbsp; Type trends

2.5&nbsp;&nbsp;&nbsp; Cancer type trends

2.6&nbsp;&nbsp;&nbsp; End-user trends

Chapter 3&nbsp;&nbsp;&nbsp;Cancer Stem Cells Therapy Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032 (USD Million)

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing cases of cancer

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing private and public initiatives

3.2.1.3&nbsp;&nbsp;&nbsp;Rising awareness regarding availability of stem cell therapy

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing research &amp; development programs

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Associated side-effects

3.2.2.2&nbsp;&nbsp;&nbsp;High cost of stem cell therapy

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By type

3.3.2&nbsp;&nbsp;&nbsp; By cancer type

3.3.3&nbsp;&nbsp;&nbsp; By end-user

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players,

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Cancer Stem Cells Therapy Market Size and Forecast, By Type, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; Targeted cancer stem cells

5.3&nbsp;&nbsp;&nbsp; Stem cells-based therapy

5.3.1&nbsp;&nbsp;&nbsp; Allogenic stem cell

5.3.2&nbsp;&nbsp;&nbsp; Autologous stem cell

Chapter 6&nbsp;&nbsp;&nbsp;Cancer Stem Cells Therapy Market Size and Forecast, By Cancer Type 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by cancer type

6.2&nbsp;&nbsp;&nbsp; Breast

6.3&nbsp;&nbsp;&nbsp; Lung

6.4&nbsp;&nbsp;&nbsp; Colorectal

6.5&nbsp;&nbsp;&nbsp; Prostrate

6.6&nbsp;&nbsp;&nbsp; Stomach

6.7&nbsp;&nbsp;&nbsp; Liver

6.8&nbsp;&nbsp;&nbsp; Other cancer types

Chapter 7&nbsp;&nbsp;&nbsp;Cancer Stem Cells Therapy Market Size and Forecast, By End-user, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-user

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Specialty centres

7.4&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Cancer Stem Cells Therapy Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Gamida Cells

9.2&nbsp;&nbsp;&nbsp; AbbVie Inc

9.3&nbsp;&nbsp;&nbsp; Astellas Pharma Inc

9.4&nbsp;&nbsp;&nbsp; Novadip Biosciences

9.5&nbsp;&nbsp;&nbsp; ReNeuron Group plc

9.6&nbsp;&nbsp;&nbsp; Celyad

9.7&nbsp;&nbsp;&nbsp; Adna GmBH

9.8&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

9.9&nbsp;&nbsp;&nbsp; Genentech Inc

9.10&nbsp;&nbsp;&nbsp; Merck KGaA 
&nbsp;

Cancer Stem Cells Therapy Market

Get a free sample of this report